1-13 of 13
Lisa Nodzon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Real-World Safety and Tolerability of Pirtobrutinib Among Patients with B Cell Lymphomas; A Single Center Experience

Mohammad Ammad Ud Din, Katherine Tobon, Julio C. Chavez, Lisa Nodzon, Hayder Saeed, Sameh Gaballa, Ning Dong, Leidy Lismeris Isenalumhe, Celeste M. Bello, Ariel Grajales-Cruz, Kenneth H. Shain, Lubomir Sokol, Bijal D Shah, Javier Pinilla-Ibarz
Journal: Blood
Blood (2024) 144 (Supplement 1): 6778.
https://doi.org/10.1182/blood-2024-208769
Published: 2024
Journal Articles

Clinical Characteristics, Treatment Strategies, and Outcomes for CLL Patients with BTK Mutation; A Single Center Study

Mohammad Ammad Ud Din, Todd C Knepper, Julio C. Chavez, Lisa Nodzon, Hayder Saeed, Sameh Gaballa, Lubomir Sokol, Ning Dong, Leidy Lismeris Isenalumhe, Celeste M. Bello, Bijal D. Shah, Javier Pinilla-Ibarz
Journal: Blood
Blood (2023) 142 (Supplement 1): 1911.
https://doi.org/10.1182/blood-2023-179658
Published: 2023
Journal Articles

Treatment Free Remission in Patients with Chronic Phase CML: A Single Center Experience

Quinto J Gesiotto, Akriti G Jain, Somedeb Ball, Lisa Nodzon, Amanda Rodriguez, Rami S. Komrokji, David A. Sallman, Eric Padron, Andrew T. Kuykendall, Onyee Chan, Jeffrey E. Lancet, Javier Pinilla Ibarz, Kendra Sweet
Journal: Blood
Blood (2021) 138 (Supplement 1): 3612.
https://doi.org/10.1182/blood-2021-152787
Published: 2021
Journal Articles

Incidence of Pleural Effusion with Dasatinib and the Effect of Switching Therapy to Bosutinib in Patients with Chronic Phase CML

Akriti G Jain, Quinto J Gesiotto, Somedeb Ball, Lisa Nodzon, Amanda Rodriguez, Rami S. Komrokji, David A. Sallman, Eric Padron, Andrew T. Kuykendall, Onyee Chan, Jeffrey E. Lancet, Javier Pinilla Ibarz, Kendra Sweet
Journal: Blood
Blood (2021) 138 (Supplement 1): 1484.
https://doi.org/10.1182/blood-2021-152017
Published: 2021
Journal Articles

A Phase II Trial of Ibrutinib and PD-1 Blockade in Asymptomatic High Risk Chronic Lymphocytic Leukemia to Improve Immune Function

Julio C. Chavez, MD, Ariel F Grajales-Cruz, MD, Virginia Olivia Volpe, MD, Elyce P. Turba, MSN, RN, Lisa Nodzon, PhD ARNP, AOCNP, Eva Sahakian, PhD, Nicole Rozario, Javier Pinilla Ibarz, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5483.
https://doi.org/10.1182/blood-2019-132211
Published: 2019
Journal Articles

Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Retrospective, Single-Institution Analysis Based on Risk Features and Debulking Strategy with Anti-CD20 Monoclonal Antibody

Ariel F Grajales-Cruz, MD, Julio Chavez, Virginia Olivia Volpe, MD, Jose Sandoval-Sus, MD, Bijal Shah, MD, Celeste Bello, MD, Lubomir Sokol, MD PhD, Shanel Fisher, Rajesh R Nair, PhD, Yun Seongseok, MD, Hayder Saeed, MD, Leidy Isenalumhe, MD, Elyce P. Turba, MSN, RN, Lisa Nodzon, PhD ARNP, AOCNP, Javier Pinilla Ibarz, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5484.
https://doi.org/10.1182/blood-2019-129260
Published: 2019
Journal Articles

Conventional Real Time Quantitative Polymerase Chain Reaction Method Yields Similar Level of Sensitivity to Digital Droplet Polymerase Chain Reaction for Detection of BCR-ABL p210 Transcripts in Patients with Chronic Phase Chronic Myeloid Leukemia

Hannah Asghari, MD BS, Chetasi Talati, MD, Alexandra Achille, John J. Powers, BS, Eva Sahakian, PhD, Onyee Chan, MD, Dawne N Shelton, PhD, Leidy Isenalumhe, MD, Lisa Nodzon, PhD ARNP, AOCNP, Kendra L. Sweet, MD, Javier Pinilla Ibarz, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3382.
https://doi.org/10.1182/blood-2019-131207
Published: 2019
Journal Articles

Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia

Ariel Felipe Grajales-Cruz, MD, Julio C. Chavez, MD, Elyce P. Turba, MSN, RN, Lisa Nodzon, PhD ARNP, AOCNP, Francisco Perez Leal, MD, Jose Sandoval-Sus, MD, Rami S. Komrokji, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Bijal D. Shah, MD, Lubomir Sokol, MD PhD, Celeste M. Bello, MD, Javier Pinilla Ibarz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3150.
https://doi.org/10.1182/blood-2018-99-111564
Published: 2018
Journal Articles

Supporting Adherence to Tyrosine Kinase Inhibitor (TKI) Therapy Among Patients with Chronic Myeloid Leukemia (CML)

Lisa Nodzon, PhD ARNP, AOCNP, Sara Tinsley-Vance, PhD ARNP, AOCN
Journal: Blood
Blood (2017) 130 (Supplement 1): 5624.
https://doi.org/10.1182/blood.V130.Suppl_1.5624.5624
Published: 2017
Journal Articles

A Phase I Study of Ruxolitinib Plus Nilotinib in Chronic Phase CML Patients with Molecular Evidence of Disease

Kendra L. Sweet, MD, Lori Hazlehurst, PhD, Eva Sahakian, PhD, John J. Powers, B.S., Lisa Nodzon, PhD ANP, Fadi Kayali, MD, Kelly Hyland, Ashley Nelson, Javier Pinilla-Ibarz, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1892.
https://doi.org/10.1182/blood.V128.22.1892.1892
Published: 2016
Journal Articles

Mutational Landscape of Chronic Lymphocytic Leukemia Using Next Generation Sequencing Technologies in the Real World Clinical Setting

Jose D Sandoval-Sus, MD, Facundo E. Stingo, MD, Todd C. Knepper, PharmD, Lisa Nodzon, PhDANP, Eric Padron, MD, Mohamed A Kharfan-Dabaja, MD, Julio C. Chavez, MD, Javier Pinilla-Ibarz, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4366.
https://doi.org/10.1182/blood.V128.22.4366.4366
Published: 2016
Journal Articles

Sequential Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide Is a Safe and Effective Regimen for the Treatment of Previously Treated and Untreated CLL/SLL: The Hilo Trial

Javier Pinilla-Ibarz, Julio C Chavez, MD, Elyce Turba, RN, MSN, OCN, Lisa Nodzon, PhDANP, Jennifer rock-Klotz, BA, Samir Dalia, MD, Rami S. Komrokji, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Celeste M. Bello, MD
Journal: Blood
Blood (2015) 126 (23): 2941.
https://doi.org/10.1182/blood.V126.23.2941.2941
Published: 2015
Journal Articles

Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia after Ibrutinib Discontinuation Outside Clinical Trials: A Single Institution Experience

Jose D Sandoval-Sus, MD, Julio C Chavez, MD, Samir Dalia, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Viet Q. Ho, PharmD, RPh, BCOP, Lisa Nodzon, PhDANP, Mohamed A. Kharfan-Dabaja, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, MD PhD, Javier Pinilla-Ibarz
Journal: Blood
Blood (2015) 126 (23): 2945.
https://doi.org/10.1182/blood.V126.23.2945.2945
Published: 2015